Outside the Box at ASCO 2018 – Ketogenic diets in colon cancer and lymphoma
This year we have exciting news here for all ketogenic diet followers! Not just one, but two clinical abstracts were accepted for online publication as part of ASCO 2018, the yearly mega conference of US and international oncology experts and professionals.
The much awaited annual American Society of Clinical Oncology ASCO annual meeting (Chicago June 1-5) will attract approximately 40,000 attendees (oncologists , pharmacists, businessmen, students, researchers) from all over the United States as well as leading cancer experts from over 100 countries. Most of the breaking news that will emerge from this conference deal with new drugs and combinations of previous chemotherapy drugs. For 2018, under the category of new targets and therapies many will see something that seems outside the box, but isn't really new to most of us...
I am especially pleased to see that our abstract proposal “Modified Ketogenic diet in lymphoma: a case series in the Veteran Affairs Pittsburgh Healthcare System", was accepted this year for online presentation.
But , we are not alone. This year , a group of Japanese researchers led by Furukawa et al also presented their abstract “Clinical effects of one year of chemotherapy with a modified medium chain triglyceride ketogenic diet on the recurrence of Stage IV colon cancer."
In this abstract, they reported ten patients with Stage IV recurrent colon cancer , all of whom could not tolerate conventional chemotherapy nor best supportive care. These patients were given chemotherapy in addition to a modified medium chain triglyceride MCT Ketogenic diet. For comparison, fourteen patients, also with stage four relapsed colon cancer , were given chemotherapy alone. When they compared the two groups they discovered that although the weights and serum albumin levels did not differ much between the two groups, the blood levels of ketones were significantly higher in the Ketogenic diet group. What's more, the group that received chemotherapy plus the modified MCT Ketogenic diet did much better in terms of tumor shrinkage and response compared to the group that did not diet at all. They found a 21% response rate for non dieters versus a 60% response rate in the Ketogenic dieters.
http://abstracts.asco.org/214/AbstView_214_214327.html
Our abstract reported on a small case series of lymphoma patients who self administered the modified ketogenic diet, and their clinical course over one to two years. Unlike the Japanese report, all of the lymphoma patients lost significant amounts of body weight . In addition , they also had increased serum /blood levels of ketones. All three patients improved clinically with improvement of their symptoms. Out of the three, two had complete disappearance of their disease on subsequent full body scans.
http://abstracts.asco.org/214/AbstView_214_222321.html
This is by no means definite evidence that the diet works since the patient numbers are very small. However it is indeed ground breaking and is a step in the right direction. Hopefully it will fuel further excitement and research on this very exciting topic.

